Pathway Health Corp. (TSXV: PHC) (Frankfurt: KL1) is set to use its medical cannabis platform to train some pharmacists in Ontario so that they can assess patients better when considering medical cannabis.
On Monday, the company announced the agreement with Sunshine Drugs, which is a family of 15 community-based pharmacies located primarily in Southwest Ontario.
The agreement implements Pathway’s Medical Cannabis Management System (MCMS) which gives access to the accredited continuing education course “Cannabis and Patient Care for Pharmacists” and trains pharmacists in patient assessment and prescription reviews.
The course meets the requirements of the Canadian Council on Continuing Education in Pharmacy (CCCEP) and the Ontario College of Pharmacists. The company’s next step will be to implement the MCMS in various Sunshine Pharmacy locations across Canada.
The program was designed to be offered at pharmacies and give access points for medical cannabis care. It aims to enable pharmacists in medical cannabis assessments for eligible patients.
Under the MCMS, patients are then connected to their own doctor or a Pathway physician or nurse practitioner for further evaluation. The MCMS has also been designed to be integrated into a formal medication review for the pharmacist.
The program offers patient assessment tools including consent forms, marketing material and additional continuing education opportunities.
Read more: Pathway starts trading on Frankfurt Stock Exchange
Read more: Pathway adds its medical cannabis system to Metro stores in Ontario
“We’re pleased to add the Sunshine Drugs group of pharmacies to the continued increasing roster of Canadian locations involved with the MCMS program. The Sunshine Drugs Family of Pharmacies is a leader in the transformation of healthcare services from a product-focused model to a patient-centric approach that customizes each patient’s healthcare plan,” Pathway Health CEO Ken Yoon said.
“As we anticipate changes from Health Canada to allow for the sale of Cannabis Health Products in pharmacies, forward-thinking chains are staking their position as the leaders in education, advice and safety for consumers researching medical cannabis,” Yoon added.
